 Samuel Gubbels
Concepts (363)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroma, Acoustic | 9 | 2024 | 41 | 3.300 |
Why?
| | Cochlear Implants | 8 | 2023 | 105 | 3.290 |
Why?
| | Cochlear Implantation | 8 | 2023 | 88 | 2.830 |
Why?
| | Cochlea | 10 | 2024 | 100 | 2.690 |
Why?
| | Speech Perception | 6 | 2024 | 82 | 2.180 |
Why?
| | Hearing Loss | 7 | 2022 | 209 | 2.160 |
Why?
| | Hearing | 8 | 2023 | 134 | 1.560 |
Why?
| | Audiometry, Pure-Tone | 5 | 2024 | 27 | 1.540 |
Why?
| | Semicircular Canals | 4 | 2021 | 29 | 1.460 |
Why?
| | Ear, Inner | 6 | 2024 | 44 | 1.250 |
Why?
| | Nestin | 3 | 2024 | 19 | 1.240 |
Why?
| | Radiosurgery | 3 | 2019 | 316 | 1.090 |
Why?
| | Otitis Media | 7 | 2022 | 163 | 1.090 |
Why?
| | Deafness | 5 | 2023 | 80 | 1.060 |
Why?
| | Otitis Media with Effusion | 3 | 2014 | 23 | 0.930 |
Why?
| | Vestibule, Labyrinth | 2 | 2024 | 66 | 0.920 |
Why?
| | Hair Cells, Auditory | 5 | 2024 | 41 | 0.890 |
Why?
| | Nasopharyngeal Diseases | 2 | 2014 | 5 | 0.870 |
Why?
| | Unnecessary Procedures | 2 | 2014 | 48 | 0.830 |
Why?
| | Gentamicins | 1 | 2023 | 52 | 0.830 |
Why?
| | Labyrinth Diseases | 3 | 2020 | 9 | 0.760 |
Why?
| | Endoscopy | 3 | 2020 | 269 | 0.760 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 23 | 0.740 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2021 | 14 | 0.730 |
Why?
| | Otolaryngologists | 1 | 2020 | 10 | 0.690 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 78 | 0.690 |
Why?
| | Ear Neoplasms | 2 | 2024 | 8 | 0.680 |
Why?
| | Paraganglioma | 1 | 2020 | 49 | 0.650 |
Why?
| | Skull Base Neoplasms | 1 | 2019 | 24 | 0.640 |
Why?
| | Temporal Bone | 6 | 2024 | 51 | 0.640 |
Why?
| | Tinnitus | 3 | 2018 | 56 | 0.630 |
Why?
| | Vertigo | 3 | 2023 | 38 | 0.620 |
Why?
| | Eustachian Tube | 1 | 2018 | 8 | 0.610 |
Why?
| | Meningioma | 1 | 2019 | 77 | 0.610 |
Why?
| | Hearing Loss, Sensorineural | 6 | 2022 | 56 | 0.610 |
Why?
| | Meningeal Neoplasms | 1 | 2019 | 88 | 0.600 |
Why?
| | Magnetic Resonance Imaging | 6 | 2023 | 3380 | 0.590 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2018 | 74 | 0.580 |
Why?
| | Hearing Aids | 2 | 2016 | 74 | 0.560 |
Why?
| | Radiation Injuries | 1 | 2018 | 139 | 0.560 |
Why?
| | Physicians' Offices | 1 | 2016 | 17 | 0.540 |
Why?
| | Humans | 62 | 2024 | 130305 | 0.520 |
Why?
| | Surgical Flaps | 2 | 2016 | 145 | 0.510 |
Why?
| | Membrane Proteins | 2 | 2020 | 1121 | 0.510 |
Why?
| | Suture Anchors | 1 | 2016 | 33 | 0.510 |
Why?
| | Sex Characteristics | 1 | 2021 | 728 | 0.500 |
Why?
| | Skin Transplantation | 1 | 2016 | 89 | 0.490 |
Why?
| | Head and Neck Neoplasms | 1 | 2020 | 533 | 0.480 |
Why?
| | Cranial Fossa, Middle | 2 | 2020 | 7 | 0.470 |
Why?
| | Benign Paroxysmal Positional Vertigo | 3 | 2021 | 4 | 0.470 |
Why?
| | Device Removal | 1 | 2016 | 143 | 0.470 |
Why?
| | Cell Differentiation | 2 | 2021 | 1896 | 0.460 |
Why?
| | Bacteriological Techniques | 1 | 2014 | 70 | 0.460 |
Why?
| | Blood | 1 | 2014 | 101 | 0.450 |
Why?
| | Hyperacusis | 1 | 2014 | 8 | 0.450 |
Why?
| | Tomography, X-Ray Computed | 7 | 2016 | 2551 | 0.450 |
Why?
| | Cholesteatoma | 1 | 2014 | 11 | 0.440 |
Why?
| | Jugular Veins | 1 | 2013 | 39 | 0.410 |
Why?
| | Glomus Jugulare Tumor | 1 | 2012 | 5 | 0.410 |
Why?
| | Polyvinyls | 1 | 2012 | 19 | 0.410 |
Why?
| | Patient Selection | 1 | 2016 | 678 | 0.410 |
Why?
| | Carotid Body Tumor | 1 | 2012 | 5 | 0.410 |
Why?
| | Otologic Surgical Procedures | 5 | 2024 | 18 | 0.400 |
Why?
| | Bacteremia | 1 | 2014 | 192 | 0.400 |
Why?
| | Influenza B virus | 1 | 2012 | 37 | 0.400 |
Why?
| | Carotid Artery, Internal | 1 | 2012 | 41 | 0.400 |
Why?
| | Cranial Nerve Diseases | 1 | 2012 | 42 | 0.400 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 745 | 0.390 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2012 | 19 | 0.390 |
Why?
| | Mutation | 2 | 2020 | 3723 | 0.390 |
Why?
| | Middle Aged | 20 | 2024 | 31322 | 0.380 |
Why?
| | Denmark | 5 | 2016 | 44 | 0.370 |
Why?
| | Stapes Surgery | 2 | 2023 | 14 | 0.370 |
Why?
| | Influenza A virus | 1 | 2012 | 104 | 0.370 |
Why?
| | Retrospective Studies | 15 | 2024 | 14675 | 0.370 |
Why?
| | Melanoma | 1 | 2018 | 757 | 0.360 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 572 | 0.360 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 147 | 0.360 |
Why?
| | Artifacts | 2 | 2023 | 124 | 0.350 |
Why?
| | Female | 26 | 2024 | 68842 | 0.350 |
Why?
| | Male | 29 | 2024 | 63748 | 0.350 |
Why?
| | Aging | 2 | 2021 | 1785 | 0.340 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.340 |
Why?
| | Embolization, Therapeutic | 1 | 2012 | 209 | 0.340 |
Why?
| | Laser Therapy | 2 | 2023 | 128 | 0.330 |
Why?
| | Adult | 21 | 2024 | 35711 | 0.330 |
Why?
| | Genetic Therapy | 5 | 2020 | 296 | 0.320 |
Why?
| | Transfection | 2 | 2009 | 910 | 0.320 |
Why?
| | Animals | 17 | 2024 | 35076 | 0.310 |
Why?
| | Mice | 11 | 2024 | 16832 | 0.310 |
Why?
| | Cerebrospinal Fluid Otorrhea | 1 | 2007 | 5 | 0.290 |
Why?
| | Bacteria | 1 | 2014 | 815 | 0.290 |
Why?
| | Encephalocele | 1 | 2007 | 6 | 0.290 |
Why?
| | Nasopharynx | 2 | 2022 | 67 | 0.290 |
Why?
| | Urinary Tract Infections | 2 | 2022 | 148 | 0.280 |
Why?
| | Intensive Care Units | 1 | 2012 | 742 | 0.280 |
Why?
| | Uterus | 1 | 2008 | 205 | 0.280 |
Why?
| | Hearing Tests | 2 | 2020 | 48 | 0.280 |
Why?
| | Cross Infection | 2 | 2022 | 203 | 0.280 |
Why?
| | Aged | 14 | 2024 | 22282 | 0.280 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 245 | 0.260 |
Why?
| | Neurons | 1 | 2015 | 1454 | 0.260 |
Why?
| | Tracheal Diseases | 1 | 2006 | 16 | 0.260 |
Why?
| | Bioprosthesis | 1 | 2006 | 40 | 0.260 |
Why?
| | Influenza, Human | 1 | 2012 | 606 | 0.260 |
Why?
| | Petrous Bone | 1 | 2024 | 7 | 0.240 |
Why?
| | Cholesteatoma, Middle Ear | 1 | 2024 | 3 | 0.240 |
Why?
| | Treatment Outcome | 10 | 2024 | 10341 | 0.240 |
Why?
| | Trachea | 1 | 2006 | 228 | 0.230 |
Why?
| | Airway Obstruction | 1 | 2006 | 157 | 0.230 |
Why?
| | Saccule and Utricle | 1 | 2024 | 6 | 0.230 |
Why?
| | Incidence | 5 | 2016 | 2657 | 0.220 |
Why?
| | Audiometry | 2 | 2014 | 27 | 0.220 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2003 | 14 | 0.220 |
Why?
| | Cadaver | 5 | 2023 | 336 | 0.210 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2003 | 43 | 0.210 |
Why?
| | Penicillins | 1 | 2023 | 58 | 0.210 |
Why?
| | Meniere Disease | 1 | 2023 | 31 | 0.200 |
Why?
| | Neurofibromatosis 2 | 1 | 2022 | 4 | 0.200 |
Why?
| | Synapses | 2 | 2021 | 386 | 0.200 |
Why?
| | Migraine Disorders | 1 | 2023 | 91 | 0.190 |
Why?
| | Haemophilus Infections | 1 | 2022 | 40 | 0.190 |
Why?
| | Aged, 80 and over | 6 | 2016 | 7128 | 0.190 |
Why?
| | Microsurgery | 2 | 2020 | 69 | 0.190 |
Why?
| | Stem Cell Transplantation | 2 | 2021 | 167 | 0.190 |
Why?
| | Otolithic Membrane | 1 | 2021 | 4 | 0.190 |
Why?
| | Labyrinthitis | 1 | 2021 | 2 | 0.190 |
Why?
| | Neurons, Efferent | 1 | 2021 | 8 | 0.180 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 575 | 0.180 |
Why?
| | Vestibular Nerve | 1 | 2021 | 16 | 0.180 |
Why?
| | Vestibular Diseases | 1 | 2021 | 25 | 0.180 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 514 | 0.180 |
Why?
| | Plasminogen | 1 | 2020 | 32 | 0.170 |
Why?
| | Mice, Transgenic | 2 | 2016 | 2107 | 0.170 |
Why?
| | Scoliosis | 1 | 2023 | 206 | 0.170 |
Why?
| | Noise | 1 | 2021 | 72 | 0.170 |
Why?
| | Ear, Middle | 4 | 2022 | 93 | 0.170 |
Why?
| | Magnets | 1 | 2019 | 19 | 0.160 |
Why?
| | Hypersensitivity | 1 | 2023 | 280 | 0.160 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 25 | 0.160 |
Why?
| | Microbiota | 3 | 2022 | 726 | 0.160 |
Why?
| | Hearing Loss, Sudden | 1 | 2018 | 5 | 0.150 |
Why?
| | Hearing Loss, Bilateral | 1 | 2018 | 13 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 321 | 0.150 |
Why?
| | Mucous Membrane | 1 | 2018 | 124 | 0.140 |
Why?
| | Surgical Equipment | 1 | 2017 | 13 | 0.140 |
Why?
| | Neurotology | 1 | 2017 | 1 | 0.140 |
Why?
| | Hearing Loss, Noise-Induced | 1 | 2017 | 16 | 0.140 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 111 | 0.140 |
Why?
| | Hospitals | 3 | 2022 | 641 | 0.140 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5365 | 0.140 |
Why?
| | Genetic Testing | 1 | 2020 | 430 | 0.140 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 394 | 0.140 |
Why?
| | Dissection | 1 | 2017 | 56 | 0.130 |
Why?
| | Infant | 7 | 2019 | 9049 | 0.130 |
Why?
| | Regeneration | 1 | 2018 | 179 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 642 | 0.130 |
Why?
| | Patient Positioning | 1 | 2017 | 51 | 0.130 |
Why?
| | Diagnosis, Differential | 5 | 2021 | 1442 | 0.130 |
Why?
| | Electrodes, Implanted | 1 | 2016 | 103 | 0.130 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 172 | 0.130 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 780 | 0.130 |
Why?
| | Adolescent | 8 | 2023 | 20374 | 0.130 |
Why?
| | Age Factors | 3 | 2012 | 3153 | 0.130 |
Why?
| | Hearing Loss, Unilateral | 1 | 2016 | 9 | 0.130 |
Why?
| | Organogenesis | 1 | 2016 | 57 | 0.130 |
Why?
| | Automation | 1 | 2016 | 83 | 0.130 |
Why?
| | Child, Preschool | 7 | 2019 | 10514 | 0.130 |
Why?
| | Scalp | 1 | 2016 | 36 | 0.130 |
Why?
| | Epidemiological Monitoring | 1 | 2016 | 50 | 0.130 |
Why?
| | Plant Lectins | 1 | 2015 | 8 | 0.120 |
Why?
| | Ifosfamide | 1 | 2015 | 33 | 0.120 |
Why?
| | Estrogen Antagonists | 1 | 2015 | 45 | 0.120 |
Why?
| | Child | 9 | 2023 | 20961 | 0.120 |
Why?
| | Durapatite | 2 | 2021 | 35 | 0.120 |
Why?
| | Quality of Life | 3 | 2023 | 2735 | 0.120 |
Why?
| | Etoposide | 1 | 2015 | 149 | 0.120 |
Why?
| | Ki-67 Antigen | 1 | 2015 | 109 | 0.120 |
Why?
| | Educational Measurement | 1 | 2017 | 264 | 0.120 |
Why?
| | Audiology | 1 | 2014 | 19 | 0.110 |
Why?
| | Pedigree | 3 | 2020 | 493 | 0.110 |
Why?
| | Tamoxifen | 1 | 2015 | 199 | 0.110 |
Why?
| | Animals, Newborn | 1 | 2016 | 822 | 0.110 |
Why?
| | Luminescent Proteins | 1 | 2015 | 180 | 0.110 |
Why?
| | Methotrexate | 1 | 2015 | 250 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2017 | 3069 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 939 | 0.110 |
Why?
| | Vestibular Evoked Myogenic Potentials | 1 | 2013 | 3 | 0.110 |
Why?
| | Young Adult | 6 | 2019 | 12404 | 0.110 |
Why?
| | Eye Movement Measurements | 1 | 2013 | 13 | 0.110 |
Why?
| | Head Injuries, Closed | 2 | 2014 | 50 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1712 | 0.100 |
Why?
| | Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2012 | 4 | 0.100 |
Why?
| | Follow-Up Studies | 5 | 2010 | 4961 | 0.100 |
Why?
| | Oral Surgical Procedures | 2 | 2011 | 6 | 0.100 |
Why?
| | Central Nervous System Cysts | 1 | 2012 | 13 | 0.100 |
Why?
| | Disease Notification | 1 | 2012 | 12 | 0.100 |
Why?
| | Salmonella Food Poisoning | 1 | 2012 | 11 | 0.100 |
Why?
| | Meat Products | 1 | 2012 | 25 | 0.100 |
Why?
| | Food Contamination | 1 | 2012 | 43 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1714 | 0.100 |
Why?
| | Seasons | 1 | 2014 | 503 | 0.100 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 429 | 0.100 |
Why?
| | Laryngoscopy | 1 | 2013 | 100 | 0.100 |
Why?
| | Biomedical Research | 1 | 2018 | 658 | 0.100 |
Why?
| | Disease Progression | 1 | 2019 | 2639 | 0.090 |
Why?
| | Phenotype | 1 | 2020 | 3084 | 0.090 |
Why?
| | Labyrinth Supporting Cells | 1 | 2011 | 3 | 0.090 |
Why?
| | Organ of Corti | 1 | 2011 | 14 | 0.090 |
Why?
| | Foodborne Diseases | 1 | 2012 | 48 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 1974 | 0.090 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2011 | 8 | 0.090 |
Why?
| | Age Distribution | 1 | 2012 | 379 | 0.090 |
Why?
| | Viral Tropism | 1 | 2011 | 29 | 0.090 |
Why?
| | Sex Distribution | 1 | 2012 | 361 | 0.090 |
Why?
| | Radiography | 1 | 2014 | 874 | 0.090 |
Why?
| | Skull Base | 2 | 2021 | 42 | 0.090 |
Why?
| | Ear Canal | 1 | 2011 | 16 | 0.090 |
Why?
| | Ganglion Cysts | 1 | 2011 | 9 | 0.090 |
Why?
| | Ear Diseases | 1 | 2011 | 14 | 0.090 |
Why?
| | Sex Factors | 2 | 2014 | 1965 | 0.090 |
Why?
| | Neurosurgical Procedures | 1 | 2012 | 171 | 0.090 |
Why?
| | Lasers | 2 | 2023 | 132 | 0.090 |
Why?
| | Cranial Nerve Neoplasms | 1 | 2010 | 7 | 0.090 |
Why?
| | Dependovirus | 1 | 2011 | 60 | 0.090 |
Why?
| | Zygoma | 1 | 2010 | 11 | 0.090 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1854 | 0.090 |
Why?
| | Salmonella typhimurium | 1 | 2012 | 177 | 0.090 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 238 | 0.090 |
Why?
| | Adenoviridae | 1 | 2011 | 194 | 0.090 |
Why?
| | Cost of Illness | 1 | 2012 | 292 | 0.080 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 160 | 0.080 |
Why?
| | Abscess | 1 | 2010 | 73 | 0.080 |
Why?
| | Genetic Vectors | 1 | 2011 | 314 | 0.080 |
Why?
| | Clinical Competence | 1 | 2017 | 1029 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2549 | 0.080 |
Why?
| | Electroencephalography | 1 | 2012 | 393 | 0.080 |
Why?
| | Maxilla | 1 | 2009 | 33 | 0.080 |
Why?
| | Disease Outbreaks | 1 | 2012 | 334 | 0.080 |
Why?
| | Skull Fractures | 1 | 2009 | 32 | 0.080 |
Why?
| | Prospective Studies | 3 | 2012 | 7131 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 643 | 0.080 |
Why?
| | Population Surveillance | 1 | 2012 | 429 | 0.080 |
Why?
| | Comorbidity | 1 | 2014 | 1555 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2016 | 2381 | 0.080 |
Why?
| | Electroporation | 1 | 2009 | 37 | 0.080 |
Why?
| | Middle Ear Ventilation | 1 | 2008 | 15 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 733 | 0.080 |
Why?
| | Dyneins | 1 | 2008 | 30 | 0.080 |
Why?
| | Electric Conductivity | 1 | 2008 | 94 | 0.080 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 563 | 0.080 |
Why?
| | Swine | 2 | 2012 | 744 | 0.070 |
Why?
| | Cleft Lip | 1 | 2008 | 42 | 0.070 |
Why?
| | Myosins | 1 | 2008 | 133 | 0.070 |
Why?
| | Cleft Palate | 1 | 2008 | 63 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2008 | 4044 | 0.070 |
Why?
| | Chronic Disease | 1 | 2014 | 1727 | 0.070 |
Why?
| | Bone Cements | 1 | 2007 | 44 | 0.070 |
Why?
| | Craniotomy | 1 | 2007 | 69 | 0.070 |
Why?
| | Mechanotransduction, Cellular | 1 | 2008 | 111 | 0.070 |
Why?
| | Internship and Residency | 1 | 2017 | 1060 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1579 | 0.060 |
Why?
| | Neck Dissection | 1 | 2005 | 15 | 0.060 |
Why?
| | Postoperative Care | 1 | 2007 | 246 | 0.060 |
Why?
| | Tonsillar Neoplasms | 1 | 2005 | 8 | 0.060 |
Why?
| | Prevalence | 1 | 2012 | 2576 | 0.060 |
Why?
| | Random Allocation | 1 | 2006 | 353 | 0.060 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2005 | 90 | 0.060 |
Why?
| | Neck | 1 | 2005 | 92 | 0.060 |
Why?
| | Biomarkers | 1 | 2016 | 3923 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 144 | 0.060 |
Why?
| | Rabbits | 1 | 2006 | 766 | 0.060 |
Why?
| | Neurilemmoma | 1 | 2024 | 23 | 0.060 |
Why?
| | Biopsy | 2 | 2011 | 1107 | 0.060 |
Why?
| | Models, Animal | 1 | 2006 | 373 | 0.060 |
Why?
| | Safety | 1 | 2006 | 333 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2007 | 395 | 0.050 |
Why?
| | Hearing Disorders | 1 | 2003 | 9 | 0.050 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 36 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2021 | 2511 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2014 | 5741 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2012 | 3369 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2024 | 204 | 0.050 |
Why?
| | Algorithms | 3 | 2017 | 1638 | 0.050 |
Why?
| | Eye Diseases | 1 | 2003 | 79 | 0.050 |
Why?
| | Hospitalization | 1 | 2012 | 2094 | 0.050 |
Why?
| | Hydroxyapatites | 1 | 2021 | 13 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 146 | 0.050 |
Why?
| | Esthetics | 1 | 2021 | 51 | 0.050 |
Why?
| | Diagnostic Techniques, Otological | 1 | 2021 | 2 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 63 | 0.050 |
Why?
| | Lithiasis | 1 | 2021 | 3 | 0.050 |
Why?
| | Recurrence | 1 | 2024 | 1020 | 0.050 |
Why?
| | Facial Nerve | 1 | 2021 | 35 | 0.040 |
Why?
| | Auditory Threshold | 2 | 2011 | 39 | 0.040 |
Why?
| | Infection Control | 1 | 2022 | 138 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2005 | 628 | 0.040 |
Why?
| | Nose | 1 | 2020 | 66 | 0.040 |
Why?
| | Scala Tympani | 1 | 2020 | 10 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2003 | 527 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2021 | 200 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2012 | 5400 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 50 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 523 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 76 | 0.040 |
Why?
| | Finland | 1 | 2019 | 91 | 0.040 |
Why?
| | Pregnancy | 2 | 2009 | 6301 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 206 | 0.040 |
Why?
| | Pharmacokinetics | 1 | 2018 | 25 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 185 | 0.040 |
Why?
| | Incus | 1 | 2017 | 8 | 0.040 |
Why?
| | Ear Ossicles | 1 | 2017 | 15 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 96 | 0.040 |
Why?
| | Exome | 1 | 2018 | 220 | 0.040 |
Why?
| | Stapes | 1 | 2017 | 32 | 0.030 |
Why?
| | Iatrogenic Disease | 1 | 2017 | 58 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 865 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 433 | 0.030 |
Why?
| | Pressure | 1 | 2017 | 239 | 0.030 |
Why?
| | Forecasting | 1 | 2018 | 364 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 427 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 686 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 723 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2018 | 330 | 0.030 |
Why?
| | Speech Intelligibility | 1 | 2014 | 5 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 959 | 0.030 |
Why?
| | Time | 1 | 2014 | 75 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 906 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2005 | 2078 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2786 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2074 | 0.030 |
Why?
| | Bacteriophage Typing | 1 | 2012 | 1 | 0.030 |
Why?
| | Abattoirs | 1 | 2012 | 2 | 0.030 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 20 | 0.020 |
Why?
| | Minisatellite Repeats | 1 | 2012 | 40 | 0.020 |
Why?
| | Cues | 1 | 2014 | 319 | 0.020 |
Why?
| | Microinjections | 1 | 2011 | 78 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2011 | 129 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2282 | 0.020 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 51 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2011 | 325 | 0.020 |
Why?
| | Functional Laterality | 1 | 2010 | 218 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 991 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 405 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2009 | 109 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 341 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1245 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 869 | 0.020 |
Why?
| | Gestational Age | 1 | 2011 | 868 | 0.020 |
Why?
| | Probability | 1 | 2008 | 314 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 585 | 0.020 |
Why?
| | RNA Interference | 1 | 2007 | 453 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4930 | 0.020 |
Why?
| | Fluorouracil | 1 | 2005 | 201 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 319 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2005 | 383 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2007 | 553 | 0.010 |
Why?
| | Cisplatin | 1 | 2005 | 299 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 825 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1028 | 0.010 |
Why?
| | United States | 1 | 2019 | 14110 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 3310 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 6615 | 0.010 |
Why?
|
|
Gubbels's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|